Sakahara H, Endo K, Koizumi M, Nakashima T, Okada K, Yoshida O, Masuko T, Hashimoto Y, Torizuka K
Jpn J Cancer Res. 1986 Sep;77(9):916-21.
Monoclonal antibodies HBJ127 and HBJ8, raised against T24 human bladder cancer cells, predominantly react with the cells in proliferating stages and with a portion of epithelial tumor cells, respectively. To investigate the in vivo localization of these monoclonal antibodies, the antibodies were labeled with radioiodine and indium-111 (111In) and injected into nude mice transplanted with human bladder tumors. The BT-11 bladder tumor had the highest concentration of radioiodinated HBJ127 and HBJ8 monoclonal antibodies, with 11.6 and 14.3% of the injected dose per gram and with a tumor-to-blood ratio of 2.6 and 1.6, respectively, at 4 days after the administration. An irrelevant monoclonal antibody did not show any specific accumulation in the BT-11 tumor. The 111In-labeled HBJ127 antibody was also localized in the tumor with a higher tumor-to-blood ratio than the radioiodinated antibody. The xenografted BT-11 tumor was successfully visualized with the radiolabeled HBJ127 and HBJ8 antibodies by scintigraphy. These monoclonal antibodies and the human bladder tumor xenografts may provide a good model for radioimmunoimaging and possibly therapy.
针对T24人膀胱癌细胞产生的单克隆抗体HBJ127和HBJ8,分别主要与增殖期细胞和部分上皮肿瘤细胞发生反应。为研究这些单克隆抗体在体内的定位,将抗体用放射性碘和铟-111(¹¹¹In)标记后注入移植了人膀胱肿瘤的裸鼠体内。BT-11膀胱肿瘤对放射性碘标记的HBJ127和HBJ8单克隆抗体摄取量最高,给药后4天,每克肿瘤摄取量分别为注射剂量的11.6%和14.3%,肿瘤与血液的比值分别为2.6和1.6。一种无关的单克隆抗体在BT-11肿瘤中未显示出任何特异性聚集。¹¹¹In标记的HBJ127抗体在肿瘤中的定位也具有比放射性碘标记抗体更高的肿瘤与血液比值。通过闪烁扫描法,用放射性标记的HBJ127和HBJ8抗体成功地对异种移植的BT-11肿瘤进行了显像。这些单克隆抗体和人膀胱肿瘤异种移植可能为放射免疫显像及可能的治疗提供一个良好的模型。